pyrrolidine-2,3-dicarboxylic acid has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpes, MJ; Correia, CR; Mello, CF; Roehrs, C; Rubin, MA; Sauzem, PD; Sinhorin, VD; Zimmer, MF | 1 |
1 other study(ies) available for pyrrolidine-2,3-dicarboxylic acid and Seizures
| Article | Year |
|---|---|
D,L-cis-2,3-Pyrrolidine dicarboxylate alters [3H]-L-glutamate binding and induces convulsions in mice.
Topics: Animals; Behavior, Animal; Brain Chemistry; Convulsants; Dicarboxylic Acids; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Membranes; Mice; Neuroprotective Agents; Pyrrolidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Seizures; Stereoisomerism; Structure-Activity Relationship | 2003 |